Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of two different doses of haloperidol on acute migraine headache severity
IRCT2016091215640N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of haloperidol in migraine (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Change in acute migraine headache severity. Started Mar 2015; status: completed.
02
Drugs
haloperidol
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT2016091215640N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016091215640N3.